Neutral
Last updated: 2026-04-08 15:56:01 ET
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
President dismisses concerns that bombing civilian targets would punish ordinary people and could be war crimesDonald Trump on Monday claimed that Ira...
OpenAI proposes taxes on AI profits, public wealth funds, and expanded safety nets to address job loss and inequality, blending redistribution with ca...
Strategy resumed Bitcoin purchases, acquiring 4,871 BTC for $329.9 million, while reporting a $14.46 billion unrealized loss and expanding its holding...
Marc Andreessen says AI job loss fears are “all fake” and predicts a “massive jobs boom,” as fresh US data show rising long-term unemployment ...
Gabriela Jaquez scores 21 points in routVictory margin is third-largest in NCAA historyGabriela Jaquez scored 21 points, Lauren Betts added 16 and UCL...
UConn coach’s outburst came after Final Four lossAuriemma: ‘No excuse for how I handled’ situationSouth Carolina coach says she is focused on ti...
A 59-year-old man lost 25 pounds on Foundayo, the new GLP-1 weight-loss pill
Corporate Bitcoin holders split as Strategy holds firm while Nakamoto sells at a loss, exposing risks of debt-driven accumulation and a shifting treas...
Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s WegovyThe US Food and Drug Administration (FD...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE